FDA: GM Mosquitoes Safe for Environment

Other government authorities have yet to evaluate a proposal aimed at reducing populations of Zika-carrying insects in Florida.

kerry grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, NIAIDA proposal to release genetically modified (GM) mosquitoes in Florida got a thumbs up from the US Food and Drug Administration (FDA) today (August 5). The agency said the plan “will not have significant impacts on the environment.”

Introduction of the animals—which are designed to produce short-lived young, thereby cutting down on the pest population—still requires the blessing of other government agencies.

“We’ve been developing this approach for many years, and from these results we are convinced that our solution is both highly effective and has sound environmental credentials,” Hadyn Parry, CEO of Oxitec, the firm that produced the GM insects, said in a press release.

The mutant mosquitoes are Aedes aegypti, the kind that transmit Zika, dengue, and other human diseases. A field trial of Oxitec’s insects in Brazil found that dengue cases dropped by up to 90 percent after the mosquitoes were introduced.

As Fusion reported, residents of the Florida town where the mosquitoes would arrive are not rolling out the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • kerry grens

    Kerry Grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo